Absent T Lymphocytes

Search Trials
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Status:
Recruiting
Last Changed:
Oct 5, 2021
First Changed:
Dec 1, 2016
Disease(s):
Adenoid Cystic Carcinoma
Intervention(s):
Laboratory Biomarker AnalysisNivolumabTalimogene Laherparepvec
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
Status:
Completed
Last Changed:
Nov 15, 2021
First Changed:
Aug 29, 2018
Disease(s):
Cervical Cancer
Intervention(s):
INCAGN02390
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
Status:
Terminated
Last Changed:
Jun 18, 2019
First Changed:
Jul 9, 2010
Disease(s):
Iron Overload
Intervention(s):
deferasirox
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
Status:
Completed
Last Changed:
Jul 18, 2018
First Changed:
Dec 2, 2011
Disease(s):
Adult Acute Lymphoblastic Leukemia
Intervention(s):
cefepime hydrochloride
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Status:
Terminated
Last Changed:
Nov 15, 2019
First Changed:
Apr 3, 2008
Disease(s):
Breast Cancer
Intervention(s):
flow cytometrylaboratory biomarker analysisData Collection

Connect. Empower. Inspire.